Milestones expected in 1st half of this year (from presentation)
Ethics approval for BTX 1503 Phase Ia study = Done
DEA export licenses for cannabidiol to be used in clinical studies = Done
Study commencement (and data) for BTX 1503 Phase Ia safety study = June
Study data from PermetrexTM pipeline product = Any day
Sign licensing agreement for PermetrexTM technology with external strategic partner = Any day
New patent filings on other pipeline products = Any day
Exciting times
Ann: Botanix Receives Approval for Synthetic Cannabidiol Trial, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $578.4M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 30.5¢ | 28.3¢ | $3.185M | 10.93M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 160165 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 166 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| BOT (ASX) Chart |